Partner
Jin Hwan CHUNG
Corporate Governance
Jin Hwan CHUNG is a Partner in the Corporate Practice Group and specializes in the areas of healthcare/life sciences, anti-trust and general corporate law, including mergers and acquisitions.
He provides legal representation and counsel to numerous leading pharmaceutical and medical devices companies including Archigen Biotech, AstraZeneca, BMS, Bayer, Berna Biotech (Crucell), Daiichi-Sankyo, Eisai, Johnson & Johnson, Janssen, Merck & Co., Mundipharma, Novartis, Novo Nordisk, Takeda, UCB, Boston Scientific, GE Healthcare, Johnson & Johnson Medical and Intuitive Surgical in connection with various transactions and compliance issues. He is one of the highly regarded experts in the area of healthcare compliance issues and a popular lecturer on this matter.
As part of his corporate practice, he has also been involved in numerous mergers and acquisitions deals and has advised domestic and foreign clients on anti-trust issues such as the Korea Fair Trade Commission’s investigation into the pharmaceutical industry since 2006. Mr. Chung currently serves as the co-head of the Healthcare/Life Sciences Team of Lee & Ko.
He provides legal representation and counsel to numerous leading pharmaceutical and medical devices companies including Archigen Biotech, AstraZeneca, BMS, Bayer, Berna Biotech (Crucell), Daiichi-Sankyo, Eisai, Johnson & Johnson, Janssen, Merck & Co., Mundipharma, Novartis, Novo Nordisk, Takeda, UCB, Boston Scientific, GE Healthcare, Johnson & Johnson Medical and Intuitive Surgical in connection with various transactions and compliance issues. He is one of the highly regarded experts in the area of healthcare compliance issues and a popular lecturer on this matter.
As part of his corporate practice, he has also been involved in numerous mergers and acquisitions deals and has advised domestic and foreign clients on anti-trust issues such as the Korea Fair Trade Commission’s investigation into the pharmaceutical industry since 2006. Mr. Chung currently serves as the co-head of the Healthcare/Life Sciences Team of Lee & Ko.
主要事例
- Healthcare & Life Sciences
- Advise on pharmaceutical, medical device, healthcare, cosmetic, food and dietary food regulations
- Provide antitrust and compliance advice to domestic and multinational pharmaceutical companies, medical device companies and medical institutions
- Advise on alcohol and tobacco regulations
- Advise on drug and medical device pricing & reimbursement under the National Health Insurance system
- Advise on clinical trial related matters
- Advise on corporate transactions of pharmaceutical and medical device industries including:
学歴
| 2008 | Georgetown Univ. Law Center - LL.M. |
|---|---|
| 2000 | Judicial Research & Training Institute, Supreme Court of Korea |
| 1994 | Seoul National University Graduate School of Law (Course Completion) |
| 1992 | Seoul National University College of Law - LL.B. |
言語
| Korean and English |
著書/活動
- Distribution and Marketing of Drugs (Korea Chapter): A Global Guide From Practical Law (2018, 2015, Thomson Reuters)
- Practical Law Multi-Jurisdictional Guide: Life Sciences (Korea Chapter, 2012-2015)
- Medical Advertisement and Inducement of Patients (2012, Legal Times)
- The International Comparative Legal Guide to Pharmaceutical Advertising (Korea Chapter, 2009)
